Full percutaneous decannulation of veno-arterial extracorporeal membrane oxygenation (VA-ECMO) using MANTA® and Femoseal® devices: a propensity-score based study
Main finding · Surgical revisionResult — go to the resultRelative risk 0.55 95% CI 0.32–0.94Authors' conclusion
FP-D markedly reduced bleeding, transfusion, infection, and surgical revision compared with manual compression, while preserving short-term survival.
Study context
- Population
- Patients treated with percutaneous VA-ECMO
- Participants
- 497 patients
- Exposure
- Fully percutaneous decannulation vs manual compression
- FP-Dn = 250
- Manual compression (MC)n = 247reference
- Outcome
- Surgical revision after decannulation
Methodological detailspropensity score weighting, single-centre
- Propensity score weighting
- Single-centre
Main finding
Surgical revision
Relative risk
0.55
95% CI 0.32–0.94
P = 0.0311
By group
FP-D vs MC
RR 0.55 (95% CI 0.32–0.94); P = 0.0311
As reported in the abstract
Observational data: associations, not effects.
Secondary outcomes
| Outcome | FP-D | MC | RR (95% CI) | P value | |
|---|---|---|---|---|---|
| Infection requiring surgeryPropensity score weighted | 3.7% | 8.4% | 0.44 (0.25–0.77) | P = 0.004 | |
| Major bleedingPropensity score weighted | 1.4% | 11% | 0.13 (0.06–0.30) | P < 0.0001 | |
| TransfusionPropensity score weighted | 7.1% | 45.7% | 0.16 (0.11–0.22) | P < 0.0001 | |
| 0.050.21520Relative risk (log scale) |
| Outcome | P value |
|---|---|
| 30-day death | P = 0.1316 |
Arterial lesions on systematic CT after FP-D
- Frequent but mostly silent arterial lesions after FP-D
Safety
| Outcome | FP-D | MC | RR (95% CI) | P value | |
|---|---|---|---|---|---|
| Major bleedingAfter propensity score weighting | 1.4% | 11% | 0.13 (0.06–0.30) | P < 0.0001 | |
| 0.050.21520Relative risk (log scale) |
Arterial lesions on systematic CT after FP-D
- Frequent but mostly silent arterial lesions after FP-D
Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.
Original publication
Full percutaneous decannulation of VA-ECMO using MANTA® and Femoseal® devices: a propensity-score based study. Crit Care. Published 12 April 2026. doi:10. 1186/ s13054-026-06012-x
Composed by AI from the published abstract and checked against it. How Briefs are made →